ATAI Life Sciences NV (ATAI)
2.19
+0.07
(+3.30%)
USD |
NASDAQ |
May 03, 10:06
ATAI Life Sciences Total Assets (Quarterly): 293.48M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 293.48M |
| September 30, 2023 | 308.22M |
| June 30, 2023 | 253.60M |
| March 31, 2023 | 280.72M |
| December 31, 2022 | 305.44M |
| September 30, 2022 | 342.60M |
| June 30, 2022 | 348.94M |
| Date | Value |
|---|---|
| March 31, 2022 | 383.73M |
| December 31, 2021 | 414.17M |
| September 30, 2021 | 484.11M |
| June 30, 2021 | 505.96M |
| March 31, 2021 | 145.26M |
| December 31, 2020 | 111.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
111.55M
Minimum
Dec 2020
505.96M
Maximum
Jun 2021
321.37M
Average
308.22M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Affimed NV | 107.40M |
| InflaRx NV | 132.88M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 25.43B |
| Immatics NV | 563.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.16M |
| Shareholders Equity (Quarterly) | 242.96M |
| Debt to Equity Ratio | 0.0736 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | -0.25% |